Literature DB >> 25620844

ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS.

Anirban Basu1.   

Abstract

This paper builds on the methods of local instrumental variables developed by Heckman and Vytlacil (1999, 2001, 2005) to estimate person-centered treatment (PeT) effects that are conditioned on the person's observed characteristics and averaged over the potential conditional distribution of unobserved characteristics that lead them to their observed treatment choices. PeT effects are more individualized than conditional treatment effects from a randomized setting with the same observed characteristics. PeT effects can be easily aggregated to construct any of the mean treatment effect parameters and, more importantly, are well suited to comprehend individual-level treatment effect heterogeneity. The paper presents the theory behind PeT effects, and applies it to study the variation in individual-level comparative effects of prostate cancer treatments on overall survival and costs.

Entities:  

Year:  2014        PMID: 25620844      PMCID: PMC4300990          DOI: 10.1002/jae.2343

Source DB:  PubMed          Journal:  J Appl Econ (Chichester Engl)        ISSN: 0883-7252


  22 in total

1.  Value of information on preference heterogeneity and individualized care.

Authors:  Anirban Basu; David Meltzer
Journal:  Med Decis Making       Date:  2007 Mar-Apr       Impact factor: 2.583

2.  Estimating Decision-Relevant Comparative Effects Using Instrumental Variables.

Authors:  Anirban Basu
Journal:  Stat Biosci       Date:  2011-09

3.  Individualization at the heart of comparative effectiveness research: the time for i-CER has come.

Authors:  Anirban Basu
Journal:  Med Decis Making       Date:  2009 Nov-Dec       Impact factor: 2.583

4.  Heterogeneity in action: the role of passive personalization in comparative effectiveness research.

Authors:  Anirban Basu; Anupam B Jena; Dana P Goldman; Tomas J Philipson; Robert Dubois
Journal:  Health Econ       Date:  2013-10-09       Impact factor: 3.046

5.  Prostate cancer--uncertainty and a way forward.

Authors:  Ian M Thompson; Catherine M Tangen
Journal:  N Engl J Med       Date:  2012-07-19       Impact factor: 91.245

6.  The impact of comparative effectiveness research on health and health care spending.

Authors:  Anirban Basu; Anupam B Jena; Tomas J Philipson
Journal:  J Health Econ       Date:  2011-06-01       Impact factor: 3.883

7.  What changes in survival rates tell us about us health care.

Authors:  Peter A Muennig; Sherry A Glied
Journal:  Health Aff (Millwood)       Date:  2010-10-07       Impact factor: 6.301

8.  Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Authors:  Anna Bill-Axelson; Lars Holmberg; Frej Filén; Mirja Ruutu; Hans Garmo; Christer Busch; Stig Nordling; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

9.  PRODUCTIVITY SPILLOVERS IN HEALTHCARE: EVIDENCE FROM THE TREATMENT OF HEART ATTACKS.

Authors:  Amitabh Chandra; Douglas O Staiger
Journal:  J Polit Econ       Date:  2007

10.  Studying radiation therapy using SEER-Medicare-linked data.

Authors:  Beth A Virnig; Joan L Warren; Gregory S Cooper; Carrie N Klabunde; Nicola Schussler; Jean Freeman
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

View more
  19 in total

1.  Are Elderly Patients With Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects.

Authors:  Anirban Basu; John L Gore
Journal:  Med Care       Date:  2015-01       Impact factor: 2.983

2.  Heterogeneity in action: the role of passive personalization in comparative effectiveness research.

Authors:  Anirban Basu; Anupam B Jena; Dana P Goldman; Tomas J Philipson; Robert Dubois
Journal:  Health Econ       Date:  2013-10-09       Impact factor: 3.046

3.  Predictive Assessment of Cancer Center Catchment Area from Electronic Health Records.

Authors:  Luca Salmasi; Enrico Capobianco
Journal:  Front Public Health       Date:  2017-11-16

4.  Welfare implications of learning through solicitation versus diversification in health care.

Authors:  Anirban Basu
Journal:  J Health Econ       Date:  2015-04-20       Impact factor: 3.883

5.  Using the Bayesian credible subgroups method to identify populations benefiting from treatment: An application to the Look AHEAD trial.

Authors:  Anna Coonan; Patrick Schnell; Joel Smith; John Forbes
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

6.  A likely responder approach for the analysis of randomized controlled trials.

Authors:  Eugene Laska; Carole Siegel; Ziqiang Lin
Journal:  Contemp Clin Trials       Date:  2022-01-24       Impact factor: 2.226

7.  Local Instrumental Variable Methods to Address Confounding and Heterogeneity when Using Electronic Health Records: An Application to Emergency Surgery.

Authors:  Silvia Moler-Zapata; Richard Grieve; David Lugo-Palacios; A Hutchings; R Silverwood; Luke Keele; Tommaso Kircheis; David Cromwell; Neil Smart; Robert Hinchliffe; Stephen O'Neill
Journal:  Med Decis Making       Date:  2022-05-24       Impact factor: 2.749

8.  Understanding Treatment Effect Terminology in Pain and Symptom Management Research.

Authors:  Melissa M Garrido; Bryan Dowd; Paul L Hebert; Matthew L Maciejewski
Journal:  J Pain Symptom Manage       Date:  2016-05-21       Impact factor: 3.612

9.  Applying methods for personalized medicine to the treatment of alcohol use disorder.

Authors:  Alena Kuhlemeier; Yasin Desai; Alexandra Tonigan; Katie Witkiewitz; Thomas Jaki; Yu-Yu Hsiao; Chi Chang; M Lee Van Horn
Journal:  J Consult Clin Psychol       Date:  2021-04

10.  Comparative Effectiveness of Gastric Bypass and Vertical Sleeve Gastrectomy for Hypertension Remission and Relapse: The ENGAGE CVD Study.

Authors:  Kristi Reynolds; Lee J Barton; Anirban Basu; Heidi Fischer; David E Arterburn; Douglas Barthold; Anita Courcoulas; Cecelia L Crawford; Benjamin B Kim; Peter N Fedorka; Edward C Mun; Sameer B Murali; Robert E Zane; Karen J Coleman
Journal:  Hypertension       Date:  2021-08-09       Impact factor: 9.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.